sense and sensibility: the pros and cons of new alternatives to patent litigation
DESCRIPTION
The 2011 America Invents Act provides U.S. patent owners and potential patent challengers with new options for review of issued patents. Challengers now have four administrative routes for invalidating issued patents and patent owners have four avenues for correcting an issued patent or preemptively addressing prior art before enforcement. Armstrong Teasdale Intellectual Property and Litigation Partner Jennifer Hoekel outlines post-issuance proceedings and the pros and cons of each in this presentation.TRANSCRIPT
© 2013 Armstrong Teasdale LLP
1
© 2013 Armstrong Teasdale LLP
© 2013 Armstrong Teasdale LLP
Jennifer Hoekel
September 25, 2013
Alternatives to Patent Litigation
© 2013 Armstrong Teasdale LLP
Post-Issuance PTO Proceedings Available to Challengers Ex Parte Reexamination Inter Partes Review (IPR) Post-Grant Review (PGR) Covered Business Method (CBM) Patents
3
© 2013 Armstrong Teasdale LLP
Which PTO Decision Making Body? Ex Parte Examination:
• Central reexamination unit (CRU).
Inter Partes Review, Post Grant Review, Covered Business Method Patents:
• Patent Trial and Appeals Board (PTAB).
4
© 2013 Armstrong Teasdale LLP
When is a Challenge Allowed?
Ex Parte Reexamination• Any time during the enforceable life of a patent.
Inter Partes Review• Nine months after the patent issues or after PGR final
decision or • Within one year of filing infringement action.
Post-Grant Review• Within nine months after a patent issues.
Covered Business Method Patents• Within nine months after a patent issues, for first to file.• Anytime for others but limited prior art• Not available after August 14, 2020.
5
© 2013 Armstrong Teasdale LLP
Which Types of Patents Can be Challenged? Ex Parte Reexamination
• All patents. Inter Partes Review
• All patents. Post-Grant Review:
• With some exceptions, requires at least one claim have an effective date after March 15, 2013.
Covered Business Method Patents• Method/apparatus for operations concerning
financial products/services, without any technological inventions.
6
© 2013 Armstrong Teasdale LLP
Grounds for Invalidity or Challenge Ex Parte Reexamination
• Sections 102 and 103, based on patents and printed publications only.
Inter Partes Review• Sections 102 and 103, based on patents and printed
publications only. Post Grant Review
• Sections 101, 102, 103 and 112. Challenge under 102 and 103 may be based on prior public knowledge including prior use or sale.
Covered Business Method Patents• Sections 101, 102, 103 and 112. Challenge under 102 and
103 may be based on prior public knowledge including prior use or sale.7
© 2013 Armstrong Teasdale LLP
Patent Challenges & Discovery
Ex Parte Reexamination• No discovery.
Inter Partes Review• Discovery allowed.
Post-Grant Review• Discovery allowed.
Covered Business Method Patents• Discovery allowed.
8
© 2013 Armstrong Teasdale LLP
Standards to Initiate
Ex Parte Reexamination• Substantial new question of patentability.
Inter Partes Review• Reasonable likelihood that at least one claim is
invalid. Post-Grant Review
• More likely than not that at least one claim is invalid.
Covered Business Method Patents• More likely than not that at least one claim is
invalid. Showing Invalidity in All Cases =
Preponderance of the Evidence
9
© 2013 Armstrong Teasdale LLP
Allowability of Amendments
Ex Parte Reexamination• Yes, but cannot broaden the scope of the
patent. Inter Partes Review
• Yes. Post-Grant Review
• Yes. Covered Business Method Patents
• Yes.
10
© 2013 Armstrong Teasdale LLP
Estoppel & Challenger Anonymity Ex Parte Reexamination
• Estoppel = NO. • Challenger Anonymity = YES.
Inter Partes Review• Estoppel = YES, statutory allowance. • Challenger Anonymity = NO.
Post-Grant Review• Estoppel = YES, statutory allowance.• Challenger Anonymity = NO.
Covered Business Method Patents• Estoppel = YES, with some limits. • Challenger Anonymity = NO.11
© 2013 Armstrong Teasdale LLP
Availability of Appeal
Ex Parte Reexamination• NO - Patentee only.
Inter Partes Review• YES - Direct appeal to Fed Cir.
Post-Grant Review• YES - Direct appeal to Fed Cir.
Covered Business Method Patents• YES - Direct Appeal to Fed Cir.
12
© 2013 Armstrong Teasdale LLP
Challenger’s Advantages and Disadvantages to Reexam Advantages
• Cheaper• Anonymity• No estoppel • Possible litigation
stay
Disadvantages
• Slower • No participation
other than by patentee
• No discovery• Claim amendments
13
© 2013 Armstrong Teasdale LLP
Challenger’s Advantages and Disadvantages to IPR Advantages
• Lower burden• Fast• Litigation stay likely• Discovery/
Adversarial• Amendments can
give intervening rights
• Preserve some defenses
Disadvantages• Expensive • One chance• No anonymity • Amendments could
strengthen patent• Stronger patent
possible
14
© 2013 Armstrong Teasdale LLP
Challenger’s Advantages and Disadvantages to PGR Advantages
• Lower burden• All statutory bases
available • Fast• Litigation stay likely• Discovery/
Adversarial
Disadvantages • Broad estoppel• Expensive• One chance• No anonymity • Amendments could
strengthen patent• Stronger patent
possible
15
© 2013 Armstrong Teasdale LLP
Challenger’s Advantages and Disadvantages to CBM Advantages
• Lower burden• All statutory bases
available • Fast• Litigation stay likely• Discovery/
Adversarial
Disadvantages
• Estoppel (narrower than IPR and PGR)
• Expensive• One chance• No anonymity • Amendments could
strengthen patent• Stronger patent
possible16
© 2013 Armstrong Teasdale LLP
Post Issuance PTO Proceedings Available to Patent Holders Ex Parte Reexamination Supplemental Examination Reissue Certificate of Correction
17
© 2013 Armstrong Teasdale LLP
Which PTO Decision Making Body? Ex Parte Reexamination
• Central reexamination unit (CRU). Supplemental Examination
• Central reexamination unit (CRU). Reissue
• Examiner. Certificate of Correction
• Supervisory examiner (except that Certificate of Corrections Branch may handle errors that are clearly minor, clerical or topographical).
18
© 2013 Armstrong Teasdale LLP
When is a Challenge Allowed?
Ex Parte Reexamination• Any time during the enforceable life of a
patent. Supplemental Examination
• Any time during the enforceable life of any patent that was enforceable on or after September 16, 2012.
Reissue • Any time during the enforceable life of a
patent. Certificate of Correction
• Any time during the enforceable life of a patent.
19
© 2013 Armstrong Teasdale LLP
Grounds for Invalidity or Challenge Ex Parte Reexamination
• Sections 102 and 103, based on patents and printed publications only.
Supplemental Examination• Sections 101, 102, 103 and 112. Any type of written
information “believed to be relevant to the patent.” Reissue
• Sections 101, 102, 103 and 112. Patents, printed publications, defects related to subject matter eligibility, utility, written description, enablement and clarity.
Certificate of Correction• Clerical or typographical mistakes or mistakes of “minor
character” by the applicant.• Any mistake by PTO “clearly disclosed” in PTO records.• Mistakes concerning inventorship.
20
© 2013 Armstrong Teasdale LLP
Standards to Initiate
Ex Parte Reexamination• Substantial new question of patentability.
Supplemental Examination• Substantial new question of patentability.
Reissue • Admission of defect in patent by patent owner.
Certificate of Correction• Discretionary. Proof of facts required to correct
inventorship.
21
© 2013 Armstrong Teasdale LLP
Allowability of Amendments
Ex Parte Reexamination• YES – claims can be narrowed but not broadened.
Supplemental Examination• No amendments during supplemental examination
itself. If ex parte reexamination is ordered, amendments allowed but cannot broaden.
Reissue • YES – claims can be narrowed anytime, or broadened if
at least one change that broadens claims is applied for within 2 years of grant of original patent.
Certificate of Correction• YES – but cannot add new matter or make changes that
require reexamination. 22
© 2013 Armstrong Teasdale LLP
Availability of Appeal
Ex Parte Reexamination• YES – examiner’s final rejection of any claims may be
appealed to PTAB;• Adverse decisions of PTAB are appealed to the Fed Cir.
Supplemental Examination• Denial is final and not appealable, but may petition
Director under 37 CFR 1.181. Reissue
• Appeal to PTAB. • Adverse decisions of PTAB are appealed to Fed Cir.
Certificate of Correction• Petition to Technology Center Director under 37 CFR
1.181.23
© 2013 Armstrong Teasdale LLP
Patentee’s Advantages and Disadvantages to Reexam Advantages
• Cheaper• Preemptive • Examiner Interviews• No third party
involvement
Disadvantages
• Slower • Narrowing or
rejecting of claims • Once started, it
cannot be stopped unilaterally
24
© 2013 Armstrong Teasdale LLP
Patentee’s Advantages and Disadvantages to Supplemental Examination
Advantages • Broad range of
prior art available• Inoculate against
fraud allegations• Art becomes of
record
Disadvantages
• Narrowing or rejecting of claims possible
• Slightly more expensive upfront
• No statements allowed other than explanation of relevance
25
© 2013 Armstrong Teasdale LLP
Patentee’s Advantages and Disadvantages to Reissue Advantages
• Cheaper• Broaden claims
within 2 yrs of issue• Narrow anytime
Disadvantages
• Admit defect • Slow
26
© 2013 Armstrong Teasdale LLP
Advantages and Disadvantages to Certificate of Correction Advantages
• Cheap or free • Do not need to
allege that there was no deceptive intent
• Fast
Disadvantages
• Must be clerical or a mistake of “minor character”
• Must be a mistake made in good faith
• Only for later-arising suits (will not help in a current lawsuit)
27
© 2013 Armstrong Teasdale LLP
Best Practices Follow the Rules:
• Non compliant submissions are often sent back. • PTAB will follow rules closely to keep reviews within one
year as required. Choose Your Battles Wisely:
• Narrow your arguments to increase chances of success. Make Petitions Thorough Up Front:
• It is difficult to supplement later in the process. Make Claim Construction Work for You:
• Good idea to make your case on claim construction from outset.
Put Together a Winning Team:• Include a mix of litigators and prosecutors to achieve
success.28
© 2013 Armstrong Teasdale LLP
Contact
Jennifer [email protected]
CLE and HRCI Confirmation Code: JH0912
29